PAM
JSPR icon

Panagora Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Panagora Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,543
Closed -$18.9K – 1240
2026
Q1 		$18.9K Buy
21,543
+2,181
+11% +$3.03K ﹤0.01% 1159
2025
Q4 		$35.4K Buy
+19,362
New +$38.9K ﹤0.01% 1173
2021
Q3 		– Sell
-451
Closed -$45K – 2052
2021
Q2 		$45K Sell
451
-295
-40% -$29.3K ﹤0.01% 2081
2021
Q1 		$74K Hold
746
– – ﹤0.01% 2111
2020
Q4 		$75K Sell
746
-29
-4% -$2.89K ﹤0.01% 1954
2020
Q3 		$77K Buy
+775
New +$77.5K ﹤0.01% 1913

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's JSPR Position: Q2 2026 in Review

Panagora Asset Management sold out of Jasper Therapeutics (JSPR) in Q2 2026, closing a stake of 21,543 shares — an estimated $18.9K sold.

Panagora Asset Management first reported a position in JSPR in Q3 2020 and held it in 6 quarters. The position peaked at $77K in Q3 2020. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Panagora Asset Management reported no remaining Jasper Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Panagora Asset Management sold 21,543 Jasper Therapeutics shares in Q2 2026, an estimated $18.9K.
  • Panagora Asset Management first reported a position in Jasper Therapeutics in Q3 2020 and held it in 6 quarters.
  • Panagora Asset Management's Jasper Therapeutics position peaked at $77K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.